Indication: VONVENDI [von Willebrand factor (recombinant)] is used in adults (age 18 years and older) diagnosed with von Willebrand disease to: treat and control bleeding episodes and prevent excessive bleeding during and after surgery


Established safety profile

The safety profile of VONVENDI® [von Willebrand factor (Recombinant)] was evaluated in 3 prospective, multicenter trials of patients with von Willebrand disease (VWD).4

Summary of adverse reactions in people with VWD4

System Organ Class (SOC) Adverse Reaction Number of
Participants (%)

Number of
Infusions (%)§

Cardiac Disorders Tachycardia 1 (1.25%) 1 (0.21%)
Gastrointestinal Disorders Vomiting 3 (3.75%) 4 (0.84%)
Nausea 3 (3.75%) 3 (0.63%)
General Disorders and Administration Site Conditions Infusion Site Paresthesia 1 (1.25%) 1 (0.21%)
Chest Discomfort 1 (1.25%) 1 (0.21%)
Skin and Subcutaneous Tissue Disorders Generalized Pruritus 2 (2.50%) 2 (0.42%)
Vascular Disorder Hot Flush 1 (1.25%) 1 (0.21%)
Hypertension 1 (1.25%) 2 (0.42%)
Deep Vein Thrombosis 1 (1.25%) 2 (0.42%)
Nervous System Disorders Dizziness 3 (3.75%) 3 (0.63%)
Vertigo 2 (2.50%) 3 (0.63%)
Dysgeusia 1 (1.25%) 1 (0.21%)
Tremor 1 (1.25%) 1 (0.21%)
Investigations Heart Rate Increase 1 (1.25%) 1 (0.21%)
Electrocardiogram T Wave Inversions 1 (1.25%) 1 (0.21%)

†These studies also used a recombinant factor VIII.

‡Percentages by subject were calculated using the number of all subjects who had the listed adverse events, including ALL AEs that are related.

§Total number of unique infusions after which at least one AE was reported of the respective ADR preferred term divided by total number of infusions (N) and multiplied by 100.

Selected Important Risk Information

Side effects that have been reported with VONVENDI include nausea, vomiting, tingling or burning at infusion site, chest discomfort, dizziness, hot flashes, itching, high blood pressure, muscle twitching, unusual taste, blood clots, and increased heart rate.

Tell your healthcare provider about any side effects that bother you or do not go away.

Find out about efficacy in the clinical study

VONVENDI efficacy

Find out how bleeding episodes were controlled with VONVENDI in clinical studies

See study results
Get information on dosing, and storage & handling


Get information on proper dosing, and storage & handling

Learn more

Stay Updated

Register for email from Shire and VONVENDI

Sign me up!